Tony Eight Lin

According to our database, Tony Eight Lin authored at least 4 papers between 2023 and 2026.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of three.

2026

Consensus Pharmacological Interactions for PLK2 Inhibitor Identification in Colorectal Cancer Treatment.

Yi-Wen Wu, Chun-Lin Yang, Tony Eight Lin, Yun-Hsuan Yeh, Yu-Ting Fang-Chin, Tzu-Ying Sung, Shih-Chung Yen, Jui-Hua Hsieh, Cheng-Chih Chung, Shiow-Lin Pan, Kai-Cheng Hsu

J. Chem. Inf. Model., 2026

2025

Establishment of an Integrated Model for Predicting Compound Mutagenicity with a Feature Importance Analysis.

Chao-Hsu Yang, Tony Eight Lin, Jui-Hua Hsieh, Kai-Cheng Hsu, Pei-Te Chiueh

J. Chem. Inf. Model., 2025

Identification of a Potent CDK8 Inhibitor Using Structure-Based Virtual Screening.

Tony Eight Lin, Ching-Hsuan Chou, Yi-Wen Wu, Tzu-Ying Sung, Jui-Yi Hsu, Shih-Chung Yen, Jui-Hua Hsieh, Yu-Wei Chang, Shiow-Lin Pan, Wei-Jan Huang, Kai-Cheng Hsu, Chia-Ron Yang

J. Chem. Inf. Model., 2025

2023

Establishment of extensive artificial intelligence models for kinase inhibitor prediction: Identification of novel PDGFRB inhibitors.

Ssu-Ting Lien, Tony Eight Lin, Jui-Hua Hsieh, Tzu-Ying Sung, Jun-Hong Chen, Kai-Cheng Hsu

Comput. Biol. Medicine, April, 2023